<DOC>
	<DOCNO>NCT00334568</DOCNO>
	<brief_summary>Clinical feature patient familial early onset form sporadic forms Alzheimers disease similar , although course deterioration may different . It would informative examine drug response patient Alzheimers disease certain genotype find evidence favour genotype-specific drug response may indicate genetically define phenotypic difference alzheimers disease .</brief_summary>
	<brief_title>Effects Of Rosiglitazone ( Extended Release Tablets ) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>Meets National Institute Neurological Communicative Diseases Stroke/Alzheimers Disease Related Disorders Association ( NINCDSADRDA ) criterion Alzheimers disease , regardless date diagnosis relative study entry date . Has Alzheimers disease status mild moderate , classify Mini Mental State Examination ( MMSE ) score 16 26 inclusive screening . Postmenopausal female define menopause define &gt; 6 month without menstrual period appropriate clinical profile , e.g . age appropriate , history vasomotor symptom . However indicate confirmed oestradiol FSH level consistent menopause ( accord local laboratory range ) . Women HRT ( hormone replacement therapy ) treatment , confirm postmenopausal advise use contraception . Has permanent caregiver willing attend visit , oversee subject compliance protocolspecified procedure study medication , report subject status . ( Subjects live alone nursing home eligible ) . Has history suffers claustrophobia . Is unable lie comfortably bed inside PET camera head field view least 60 minute assess physical examination medical history ( e.g . back pain , arthritis ) . Has history presence neurological medical condition may influence outcome analysis PET scan result . Examples condition include , limited stroke , traumatic brain injury , epilepsy space occupy lesion . History Type I Type II diabetes mellitus . Fasting plasma glucose level &gt; 126 mg/dL ( &gt; 7.0 mmol/L ) HbA1c &gt; 6.2 % . History clinical/laboratory evidence moderate congestive heart failure define New York Heart Association criterion ( class IIIV .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>AVANDIA</keyword>
	<keyword>Alzheimers Disease</keyword>
</DOC>